rs138845109

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_170606.3(KMT2C):​c.8502A>T​(p.Glu2834Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000535 in 1,614,192 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0030 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00028 ( 3 hom. )

Consequence

KMT2C
NM_170606.3 missense

Scores

1
2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2O:1

Conservation

PhyloP100: 0.367

Publications

4 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0035897195).
BP6
Variant 7-152176951-T-A is Benign according to our data. Variant chr7-152176951-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 134773.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.003 (457/152332) while in subpopulation AFR AF = 0.0096 (399/41570). AF 95% confidence interval is 0.00882. There are 2 homozygotes in GnomAd4. There are 223 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 457 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.8502A>T p.Glu2834Asp missense_variant Exon 38 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.8502A>T p.Glu2834Asp missense_variant Exon 38 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.00299
AC:
455
AN:
152214
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00958
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000709
AC:
178
AN:
251198
AF XY:
0.000413
show subpopulations
Gnomad AFR exome
AF:
0.00910
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000278
AC:
407
AN:
1461860
Hom.:
3
Cov.:
35
AF XY:
0.000228
AC XY:
166
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00998
AC:
334
AN:
33478
American (AMR)
AF:
0.000760
AC:
34
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111988
Other (OTH)
AF:
0.000546
AC:
33
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00300
AC:
457
AN:
152332
Hom.:
2
Cov.:
31
AF XY:
0.00299
AC XY:
223
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00960
AC:
399
AN:
41570
American (AMR)
AF:
0.00287
AC:
44
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68032
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000372
Hom.:
0
Bravo
AF:
0.00336
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000865
AC:
105
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

atypical cerebral palsy Uncertain:1
-
TIDEX, University of British Columbia
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

KMT2C-related disorder Benign:1
Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Nov 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
14
DANN
Uncertain
0.98
DEOGEN2
Benign
0.080
T;T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.28
FATHMM_MKL
Benign
0.59
D
LIST_S2
Benign
0.73
.;T
MetaRNN
Benign
0.0036
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;L
PhyloP100
0.37
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.6
N;N
REVEL
Uncertain
0.34
Sift
Pathogenic
0.0
D;D
Polyphen
0.79
P;P
Vest4
0.066
MutPred
0.087
Gain of relative solvent accessibility (P = 0.0249);Gain of relative solvent accessibility (P = 0.0249);
MVP
0.33
MPC
0.081
ClinPred
0.077
T
GERP RS
3.2
Varity_R
0.34
gMVP
0.14
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138845109; hg19: chr7-151874036; API